Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2024 ∙ Gutfreund, M. C. Kobayashi, T. Callado, G. Y. Pardo, I. Hsieh, M. K. Lin, V. Perencevich, E. N. Salinas, J. L. Edmond, M. B. Mendonça, E. Rizzo, L. V. Marra, A. R.

The effectiveness of the COVID-19 vaccines in the prevention of post-COVID conditions in children and adolescents: a systematic literature review and meta-analysis

  • Children
  • Adolescents
  • Adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Politis, M. Rachiotis, G. Mouchtouri, V. A. Hadjichristodoulou, C.

The Global Burden of Absenteeism Related to COVID-19 Vaccine Side Effects Among Healthcare Workers: A Systematic Review and Meta-Analysis

  • Healthcare workers
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Cherri, Z. Lau, K. Nellums, L. B. Himmels, J. Deal, A. McGuire, E. Mounier-Jack, S. Norredam, M. Crawshaw, A. Carter, J. Seedat, F. Clemente, N. S. Bouaddi, O. Friedland, J. S. Edelstein, M. Hargreaves, S.

The immune status of migrant populations in Europe and implications for vaccine-preventable disease control: a systematic review and meta-analysis

  • Europe
  • All age groups
  • Measles
  • Mumps
  • Rubella
  • Diphtheria
  • Coverage
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Bjerkhaug, A. U. Ramalingham, S. Mboizi, R. Le Doare, K. Klingenberg, C.

The immunogenicity and safety of Group B Streptococcal maternal vaccines: A systematic review

  • Adults
  • Pregnant women
  • Newborn
  • Streptococcus group B
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ SeyedAlinaghi, S. Amrollah, M. F. Dadras, O. Dashti, M. Ghasemzadeh, A. Afzalian, A. Varshochi, S. Parikhani, S. N. Siami, H. Nourian, A. Mehraeen, E.

The immunologic outcomes and adverse events of COVID-19 vaccine booster dose in immunosuppressed people: A systematic review

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Adamyan, L. Pivazyan, L. Krylova, E. Avetisyan, J. Murvatova, K. Obosyan, L.

The impact of SARS-CoV-2 vaccine on female fertility: a systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2024 ∙ Jomah, A. Albokhary, A.

The impact of the human papillomavirus vaccine on women's health: a systematic review

  • Adults
  • Older adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Skaarup, K. G. Lassen, M. C. H. Modin, D. Johansen, N. D. Loiacono, M. M. Harris, R. C. Lee, J. K. H. Dufournet, M. Vardeny, O. Peikert, A. Claggett, B. Solomon, S. D. Jensen, J. U. S. Biering-Sorensen, T.

The relative vaccine effectiveness of high-dose vs standard-dose influenza vaccines in preventing hospitalization and mortality: A meta-analysis of evidence from randomized trials

  • Older adults
  • Influenza
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Low
2024 ∙ Nakabembe, E. Cooper, J. Amaral, K. Tusubira, V. Hsia, Y. Abu-Raya, B. Sekikubo, M. Nakimuli, A. Sadarangani, M. Le Doare, K.

The safety and immunogenicity of vaccines administered to pregnant women living with HIV: a systematic review and meta-analysis

  • Pregnant women
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2024 ∙ Han, Y. Wang, X. Li, X. Zhong, Z.

The willingness of healthcare workers to be vaccinated against monkeypox and their knowledge about monkeypox: A systematic review and meta-analysis

  • Healthcare workers
  • Mpox
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
Loading...